,SpectrumID,X.Scan.,SpectrumFile,LibraryName,MQScore,TIC_Query,RT_Query,MZErrorPPM,SharedPeaks,MassDiff,SpecMZ,SpecCharge,FileScanUniqueID,NumberHits,Compound_Name,Ion_Source,Instrument,Compound_Source,PI,Data_Collector,Adduct,Precursor_MZ,ExactMass,Charge,CAS_Number,Pubmed_ID,Smiles,INCHI,INCHI_AUX,Library_Class,IonMode,Organism,LibMZ,UpdateWorkflowName,LibraryQualityString,tags,molecular_formula,InChIKey,InChIKey.Planar,superclass,class,subclass,npclassifier_superclass,npclassifier_class,npclassifier_pathway,library_usi,name_compound,name_parent_compound,chemical_source,pharmacologic_class,therapeutic_area,therapeutic_indication,mechanism_of_action,inchikey,smiles
1,CCMSLIB00000205786,7181,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.708754,1534400000,0,1.67604,2,0.000305176,182.081,1,temp/spectra_filtered.mgf7181,1,Massbank:CE000231 Tyrosine,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,182.081,0,1,N/A,N/A,C1=CC(=CC=C1CC(C(=O)O)N)O,"1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)",N/A,3,Positive,MASSBANK,182.081,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H11NO3,OUYCCCASQSFEME-UHFFFAOYSA-N,OUYCCCASQSFEME,N/A,N/A,N/A,Small peptides,Aminoacids,Amino acids and Peptides|Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000205786,tyrosine,tyrosine,Endogenous|Medical,no_match,NA,NA,NA,OUYCCCASQSFEME-UHFFFAOYSA-N,NC(Cc1ccc(O)cc1)C(=O)O
2,CCMSLIB00000207289,12352,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.983509,25360000,0,0,11,0,311.081,1,temp/spectra_filtered.mgf12352,1,"Massbank:EA018304 Sulfadimethoxine|4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,311.081,0,1,122-11-2,N/A,c1(NS(c2ccc(N)cc2)(=O)=O)cc(nc(n1)OC)OC,"1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)",N/A,3,Positive,MASSBANK,311.081,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C12H14N4O4S,ZZORFUFYDOWNEF-UHFFFAOYSA-N,ZZORFUFYDOWNEF,Benzenoids,Benzene and substituted derivatives,Benzenesulfonamides,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207289,sulfadimethoxine,sulfadimethoxine,Medical|Background/QAQC,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N,COc1cc(=NS(=O)(=O)c2ccc(N)cc2)[nH]c(OC)n1
3,CCMSLIB00000207393,9430,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.953436,182090000,0,1.22275,3,0.000289917,237.102,1,temp/spectra_filtered.mgf9430,1,"Massbank:EA019410 Carbamazepine|5H-Dibenz[b,f]azepine-5-carboxamide|11-benzo[b][1]benzazepinecarboxamide",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,237.102,0,1,298-46-4,N/A,N1(c2c(cccc2)C=Cc2c1cccc2)C(N)=O,"1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",N/A,3,Positive,MASSBANK,237.102,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H12N2O,FFGPTBGBLSHEPO-UHFFFAOYSA-N,FFGPTBGBLSHEPO,N/A,N/A,N/A,Anthranilic acid alkaloids,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207393,carbamazepine,carbamazepine,Medical,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,FFGPTBGBLSHEPO-UHFFFAOYSA-N,NC(=O)N1c2ccccc2C=Cc2ccccc21
4,CCMSLIB00000207429,3159,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.97614,528400000,0,1.24147,5,0.000213623,172.072,1,temp/spectra_filtered.mgf3159,1,Massbank:EA019704 Metronidazole|2-Methyl-5-nitroimidazole-1-ethanol|2-(2-methyl-5-nitro-1-imidazolyl)ethanol,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,172.072,0,1,443-48-1,N/A,CC1=NC=C(N1CCO)[N+]([O-])=O,"1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3",N/A,3,Positive,MASSBANK,172.072,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,VAOCPAMSLUNLGC-UHFFFAOYSA-N,VAOCPAMSLUNLGC,Organoheterocyclic compounds,Azoles,Imidazoles,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000207429,metronidazole,metronidazole,Medical,nitroimidazole antimicrobial,infectious disease|dermatology,gram-positive bacterial infections|gram-negative bacterial infections,DNA inhibitor,VAOCPAMSLUNLGC-UHFFFAOYSA-N,Cc1ncc([N+](=O)[O-])n1CCO
5,CCMSLIB00000208374,7507,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.988783,174270000,0,0.695589,10,0.000213623,307.111,1,temp/spectra_filtered.mgf7507,1,"Massbank:EA032804 Fluconazole|2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)-2-propanol",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,307.111,0,1,86386-73-4,N/A,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3,"1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",N/A,3,Positive,MASSBANK,307.111,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C13H12F2N6O,RFHAOTPXVQNOHP-UHFFFAOYSA-N,RFHAOTPXVQNOHP,Benzenoids,Benzene and substituted derivatives,Halobenzenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208374,fluconazole,fluconazole,Medical,azole antifungal,infectious disease,candidiasis|esophageal candidiasis|vaginal candidiasis|cryptococcal meningitis,sterol demethylase inhibitor,RFHAOTPXVQNOHP-UHFFFAOYSA-N,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F
6,CCMSLIB00000208971,4014,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.980744,352500000,0,1.8209,12,0.000488281,268.154,1,temp/spectra_filtered.mgf4014,1,Massbank:EA069704 Atenolol acid|Metoprolol acid|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,268.154,0,1,56392-14-4,N/A,CC(C)NCC(O)COc1ccc(cc1)CC(=O)O,"1S/C14H21NO4/c1-10(2)15-8-12(16)9-19-13-5-3-11(4-6-13)7-14(17)18/h3-6,10,12,15-16H,7-9H2,1-2H3,(H,17,18)",N/A,3,Positive,MASSBANK,268.154,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C14H21NO4,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,PUQIRTNPJRFRCZ,N/A,N/A,N/A,Pseudoalkaloids,Phenylalanine-derived alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208971,metoprolol acid,atenolol|metoprolol,Drug metabolite,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CC(=O)O)cc1
7,CCMSLIB00000208971,4014,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.980744,352500000,0,1.8209,12,0.000488281,268.154,1,temp/spectra_filtered.mgf4014,1,Massbank:EA069704 Atenolol acid|Metoprolol acid|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,268.154,0,1,56392-14-4,N/A,CC(C)NCC(O)COc1ccc(cc1)CC(=O)O,"1S/C14H21NO4/c1-10(2)15-8-12(16)9-19-13-5-3-11(4-6-13)7-14(17)18/h3-6,10,12,15-16H,7-9H2,1-2H3,(H,17,18)",N/A,3,Positive,MASSBANK,268.154,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C14H21NO4,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,PUQIRTNPJRFRCZ,N/A,N/A,N/A,Pseudoalkaloids,Phenylalanine-derived alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000208971,metoprolol acid,atenolol|metoprolol,Drug metabolite,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N,CC(C)NCC(O)COc1ccc(CC(=O)O)cc1
8,CCMSLIB00000209382,7474,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.862919,24590000,0,0.462044,6,0.00012207,264.196,1,temp/spectra_filtered.mgf7474,1,Massbank:EA103410 N-Desmethylvenlafaxine|1-[1-(4-methoxyphenyl)-2-(methylamino)ethyl]-1-cyclohexanol,ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,264.196,0,1,149289-30-5,N/A,CNCC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,"1S/C16H25NO2/c1-17-12-15(16(18)10-4-3-5-11-16)13-6-8-14(19-2)9-7-13/h6-9,15,17-18H,3-5,10-12H2,1-2H3",N/A,3,Positive,MASSBANK,264.196,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H25NO2,MKAFOJAJJMUXLW-UHFFFAOYSA-N,MKAFOJAJJMUXLW,Benzenoids,Phenol ethers,Anisoles,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000209382,n-desmethylvenlafaxine,venlafaxine,Drug metabolite,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N,CNCC(c1ccc(OC)cc1)C1(O)CCCCC1
9,CCMSLIB00000209983,8780,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.829446,131300000,0,1.36236,11,0.000396729,291.207,1,temp/spectra_filtered.mgf8780,1,"Massbank:EA263710 D617|Verapamil metabolite D617|2-(3,4-dimethoxyphenyl)-2-isopropyl-5-(methylamino)valeronitrile",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,291.207,0,1,34245-14-2,N/A,CC(C)C(CCCNC)(C#N)C1=CC(=C(C=C1)OC)OC,"1S/C17H26N2O2/c1-13(2)17(12-18,9-6-10-19-3)14-7-8-15(20-4)16(11-14)21-5/h7-8,11,13,19H,6,9-10H2,1-5H3",N/A,3,Positive,MASSBANK,291.207,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,WLOBUUJURNEQCL-UHFFFAOYSA-N,WLOBUUJURNEQCL,Benzenoids,Benzene and substituted derivatives,Phenylbutylamines,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000209983,d-617 (verapamil metabolite),verapamil,Drug metabolite,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N,CNCCCC(C#N)(c1ccc(OC)c(OC)c1)C(C)C
10,CCMSLIB00000210200,5764,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.951539,37770000,0,0.715214,9,0.000183105,256.015,1,temp/spectra_filtered.mgf5764,1,"Massbank:EA267604 Lamotrigine|6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine",ESI,LC-ESI-ITFT,Isolated,Putative Massbank Match,Massbank,[M+H]+,256.015,0,1,84057-84-1,N/A,Cl-c(ccc1)c(Cl)c1-c(nnc2N)c(n2)N,"1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",N/A,3,Positive,MASSBANK,256.015,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H7Cl2N5,PYZRQGJRPPTADH-UHFFFAOYSA-N,PYZRQGJRPPTADH,Benzenoids,Benzene and substituted derivatives,Halobenzenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000210200,lamotrigine,lamotrigine,Medical,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N,N=c1[nH]nc(-c2cccc(Cl)c2Cl)c(=N)[nH]1
11,CCMSLIB00000565063,20093,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.842045,111050000,0,2.37462,3,0.000396729,167.07,1,temp/spectra_filtered.mgf20093,1,MoNA:2745244 Napagin a,LC-ESI-ITFT,LC-ESI-ITFT,isolated,MoNA,MoNA,[M+H]+,167.07,0,1,N/A,N/A,CCOC(=O)c1ccc(O)cc1,"InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3",N/A,3,,MONA,167.07,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H10O3,NUVBSKCKDOMJSU-UHFFFAOYSA-N,NUVBSKCKDOMJSU,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Phenolic acids (C6-C1),Shikimic acids and derivatives|Simple phenolic acids,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000565063,ethyl hydroxybenzoate,ethyl hydroxybenzoate,Food|Medical,no_match,NA,NA,preservative,NUVBSKCKDOMJSU-UHFFFAOYSA-N,CCOC(=O)c1ccc(O)cc1
12,CCMSLIB00000577480,20253,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.762138,52230000,0,8.19273,4,0.00350952,428.374,1,temp/spectra_filtered.mgf20253,1,Sorbitane Monooleate - Polysorbate 20 in-source fragment,LC-ESI,qTof,Lysate,PDorrestein,AMelnik,M+H,428.37,0,0, , ,CCCCCCCCC=CCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)O,"InChI=1S/C24H44O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(27)29-19-21(26)24-23(28)20(25)18-30-24/h9-10,20-21,23-26,28H,2-8,11-19H2,1H3", ,3,Positive,GNPS-LIBRARY,428.37,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C24H44O6,NWGKJDSIEKMTRX-UHFFFAOYSA-N,NWGKJDSIEKMTRX,Lipids and lipid-like molecules,Fatty Acyls,Fatty acid esters,Fatty esters,Wax monoesters,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000577480,polysorbate 80,polysorbate 80,Food|Medical|Personal Care,no_match,no_match,no_match,no_match,NWGKJDSIEKMTRX-UHFFFAOYSA-N,CCCCCCCCC=CCCCCCCCC(=O)OCC(O)C1OCC(O)C1O
13,CCMSLIB00000841613,15314,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.983971,1269900000,0,1.03241,6,0.000198364,192.138,1,temp/spectra_filtered.mgf15314,1,"MassbankEU:SM822301 DEET|N,N-diethyl-3-methylbenzamide",ESI,LC-ESI-QFT,Isolated,Massbank EU,Massbank,[M+H]+,192.138,0,1,134-62-3,N/A,CCN(CC)C(=O)C1=CC(C)=CC=C1,"1S/C12H17NO/c1-4-13(5-2)12(14)11-8-6-7-10(3)9-11/h6-9H,4-5H2,1-3H3",N/A,3,Positive,MASSBANKEU,192.138,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C12H17NO,MMOXZBCLCQITDF-UHFFFAOYSA-N,MMOXZBCLCQITDF,Benzenoids,Benzene and substituted derivatives,Toluenes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00000841613,diethyltoluamide,diethyltoluamide,Medical|Personal Care,other insecticides and repellents,NA,NA,ionotropic receptor IR40a activator,MMOXZBCLCQITDF-UHFFFAOYSA-N,CCN(CC)C(=O)c1cccc(C)c1
14,CCMSLIB00003135294,8662,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.895443,4.65e+08,0,2.94294,6,0.00050354,171.102,1,temp/spectra_filtered.mgf8662,1,Spectral Match to Azelaic acid from NIST14,ESI,qTof,Isolated,Data from Christopher A. Lowry,Data deposited by fevargas,M+H-H2O,171.101,188.105,1,123999,N/A,C(CCCC(=O)O)CCCC(=O)O,"InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)",N/A,3,Positive,GNPS-NIST14-MATCHES,171.101,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H16O4,BDJRBEYXGGNYIS-UHFFFAOYSA-N,BDJRBEYXGGNYIS,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Fatty Acids and Conjugates,Dicarboxylic acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003135294,azelaic acid,azelaic acid,Endogenous|Food|Medical|Personal Care,other anti-acne preparations for topical use,dermatology,rosacea|acne,tyrosinase inhibitor,BDJRBEYXGGNYIS-UHFFFAOYSA-N,O=C(O)CCCCCCCC(=O)O
15,CCMSLIB00003135725,8723,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.707557,6.9e+07,0,17.0097,8,0.00488281,287.055,1,temp/spectra_filtered.mgf8723,1,"Spectral Match to 3,5,7,3',4'-Pentahydroxyflavanone from NIST14",ESI,qTof,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+H-H2O,287.06,304.058,1,480182,N/A,C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,"InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m0/s1",N/A,3,Positive,GNPS-NIST14-MATCHES,287.06,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H12O7,CXQWRCVTCMQVQX-LSDHHAIUSA-N,CXQWRCVTCMQVQX,Phenylpropanoids and polyketides,Flavonoids,Flavans,Flavonoids,Dihydroflavonols,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003135725,cianidanol,cianidanol,Food|Medical,no_match,NA,NA,opioid receptor antagonist,CXQWRCVTCMQVQX-LSDHHAIUSA-N,O=C1C(O)c2c(O)cc(O)cc2OC1c1ccc(O)c(O)c1
16,CCMSLIB00003136054,18285,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.989186,322600000,0,3.91121,6,0.00119019,304.3,1,temp/spectra_filtered.mgf18285,1,Spectral Match to Benzyldodecyldimethylammonium from NIST14,ESI,QQQ,Isolated,Data from Maria Maansson,Data deposited by marjo,M+,304.301,304.3,1,10328355,N/A,CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,"InChI=1S/C21H38N/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21/h13-15,17-18H,4-12,16,19-20H2,1-3H3/q+1",N/A,3,Positive,GNPS-NIST14-MATCHES,304.301,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,Cancer[Bioactivity (Active against)],N/A,CYDRXTMLKJDRQH-UHFFFAOYSA-N,CYDRXTMLKJDRQH,Benzenoids,Benzene and substituted derivatives,Phenylmethylamines,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003136054,benzalkonium,benzalkonium,Medical|Personal Care|Industrial,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N,CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1
17,CCMSLIB00003136825,15820,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.764721,562100000,0,0.57706,5,0.000106812,185.096,1,temp/spectra_filtered.mgf15820,1,Spectral Match to Cyclopentolate from NIST14,ESI,IT/ion trap,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,185.1,185.096,0,1,512152,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,185.096,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003136825,cyclopentolate,cyclopentolate,Medical,anticholinergic,ophthalmology,mydriasis|cycloplegia,acetylcholine receptor antagonist,N/A,N/A
18,CCMSLIB00003136961,33896,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.801617,57480000,0,2.05634,6,0.000915527,445.223,1,temp/spectra_filtered.mgf33896,1,Spectral Match to Dioctyl sulfosuccinate from NIST14,ESI,QqQ,Isolated,Data from Lihini Aluwihare,Data deposited by daniel,M+Na,445.222,0,1,10041197,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,445.222,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003136961,docusate sodium,docusate sodium,Medical,"softeners, emollients",gastroenterology,constipation,laxative,HNSDLXPSAYFUHK-UHFFFAOYSA-N,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O
19,CCMSLIB00003138920,20927,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.84774,271100000,0,21.9494,6,0.00379944,173.096,1,temp/spectra_filtered.mgf20927,1,Spectral Match to Formestane from NIST14,ESI,IT/ion trap,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,173.1,173.1,0,1,566483,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,173.1,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003138920,formestane,formestane,Medical,aromatase inhibitors,oncology,breast cancer,aromatase inhibitor,N/A,N/A
20,CCMSLIB00003139097,25474,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.711187,293500000,0,0,6,0,307.263,1,temp/spectra_filtered.mgf25474,1,"Spectral Match to cis-8,11,14-Eicosatrienoic acid from NIST14",ESI,qTof,Isolated,Data from Jessica Metcalf,Data deposited by mjmeehan,M+H,307.263,306.256,1,1783842,N/A,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",N/A,3,Positive,GNPS-NIST14-MATCHES,307.263,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C20H34O2,HOBAELRKJCKHQD-QNEBEIHSSA-N,HOBAELRKJCKHQD,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139097,dihomo-gamma-linolenic acid,dihomo-gamma-linolenic acid,Endogenous|Medical,no_match,NA,NA,prostanoid receptor agonist,HOBAELRKJCKHQD-QNEBEIHSSA-N,CCCCCC=CCC=CCC=CCCCCCCC(=O)O
21,CCMSLIB00003139097,25793,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.741439,517900000,0,0,6,0,307.263,1,temp/spectra_filtered.mgf25793,1,"Spectral Match to cis-8,11,14-Eicosatrienoic acid from NIST14",ESI,qTof,Isolated,Data from Jessica Metcalf,Data deposited by mjmeehan,M+H,307.263,306.256,1,1783842,N/A,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",N/A,3,Positive,GNPS-NIST14-MATCHES,307.263,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C20H34O2,HOBAELRKJCKHQD-QNEBEIHSSA-N,HOBAELRKJCKHQD,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139097,dihomo-gamma-linolenic acid,dihomo-gamma-linolenic acid,Endogenous|Medical,no_match,NA,NA,prostanoid receptor agonist,HOBAELRKJCKHQD-QNEBEIHSSA-N,CCCCCC=CCC=CCC=CCCCCCCC(=O)O
22,CCMSLIB00003139980,10110,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.775962,283900000,0,0.609961,5,0.000106812,175.112,1,temp/spectra_filtered.mgf10110,1,Spectral Match to (-)-Perillyl alcohol from NIST14,ESI,QqQ,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+Na,175.112,0,1,18457551,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,175.112,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139980,perillyl alcohol,perillyl alcohol,Food|Medical,no_match,NA,NA,apoptosis stimulant|farnesyltransferase inhibitor,NDTYTMIUWGWIMO-SNVBAGLBSA-N,C=C(C)C1CC=C(CO)CC1
23,CCMSLIB00003139980,18213,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.786768,177700000,0,0.609961,5,0.000106812,175.112,1,temp/spectra_filtered.mgf18213,1,Spectral Match to (-)-Perillyl alcohol from NIST14,ESI,QqQ,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+Na,175.112,0,1,18457551,N/A,N/A,N/A,N/A,3,Positive,GNPS-NIST14-MATCHES,175.112,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139980,perillyl alcohol,perillyl alcohol,Food|Medical,no_match,NA,NA,apoptosis stimulant|farnesyltransferase inhibitor,NDTYTMIUWGWIMO-SNVBAGLBSA-N,C=C(C)C1CC=C(CO)CC1
24,CCMSLIB00003139989,5346,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.990198,624990000,0,1.36293,11,0.000396729,291.086,1,temp/spectra_filtered.mgf5346,1,Spectral Match to (+)-Catechin from NIST14,ESI,qTof,Isolated,Data from Wolfender/Litaudon,Data deposited by pmallard,M+H,291.086,290.079,1,154234,N/A,C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,"InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1",N/A,3,Positive,GNPS-NIST14-MATCHES,291.086,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H14O6,PFTAWBLQPZVEMU-DZGCQCFKSA-N,PFTAWBLQPZVEMU,N/A,N/A,N/A,Flavonoids,Flavan-3-ols,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003139989,cianidanol,cianidanol,Food|Medical,no_match,NA,NA,fatty acid synthase inhibitor,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2
25,CCMSLIB00003142438,3792,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.884508,372700000,0,0.505615,4,9.15527e-05,181.072,1,temp/spectra_filtered.mgf3792,1,Theophylline,LC-ESI,Orbitrap,Commercial,Rafael Garrett,Najla Moufarreg,M+H,181.072,180.065,1,58-55-9,N/A,Cn1c2c(c(=O)n(c1=O)C)[nH]cn2,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",N/A,3,Positive,GNPS-LIBRARY,181.072,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C7H8N4O2,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,ZFXYFBGIUFBOJW,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Pseudoalkaloids,Purine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00003142438,theophylline,theophylline,Food|Medical,methylxanthine,pulmonary,asthma|bronchitis|emphysema,adenosine receptor antagonist,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,Cn1c(=O)c2[nH]cnc2n(C)c1=O
26,CCMSLIB00004695483,42703,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.728124,87380000,0,14.6526,6,0.00640869,437.381,1,temp/spectra_filtered.mgf42703,1,gamma-sitosterol,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF004420,[M+Na]+,437.375,0,1,N/A,N/A,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,"InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1",N/A,3,positive,MONA,437.375,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C29H50O,KZJWDPNRJALLNS-VJSFXXLFSA-N,KZJWDPNRJALLNS,Lipids and lipid-like molecules,Steroids and steroid derivatives,Stigmastanes and derivatives,Steroids,Stigmastane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004695483,sitosterol,sitosterol,Food|Medical,no_match,NA,NA,NA,KZJWDPNRJALLNS-FBZNIEFRSA-N,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C
27,CCMSLIB00004695483,42126,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.701719,68110000,0,14.6526,6,0.00640869,437.381,1,temp/spectra_filtered.mgf42126,1,gamma-sitosterol,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF004420,[M+Na]+,437.375,0,1,N/A,N/A,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,"InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1",N/A,3,positive,MONA,437.375,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C29H50O,KZJWDPNRJALLNS-VJSFXXLFSA-N,KZJWDPNRJALLNS,Lipids and lipid-like molecules,Steroids and steroid derivatives,Stigmastanes and derivatives,Steroids,Stigmastane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004695483,sitosterol,sitosterol,Food|Medical,no_match,NA,NA,NA,KZJWDPNRJALLNS-FBZNIEFRSA-N,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C
28,CCMSLIB00004721671,34721,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.821168,562940000,0,11.0614,14,0.00756836,684.203,1,temp/spectra_filtered.mgf34721,1,ACARBOSE,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF028090,[M+K]+,684.211,0,1,N/A,N/A,CC1OC(OC2C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O,"InChI=1S/C25H43NO18/c1-7-13(26-9-2-8(3-27)14(33)18(37)15(9)34)17(36)20(39)24(41-7)44-23-12(6-30)42-25(21(40)19(23)38)43-22(11(32)5-29)16(35)10(31)4-28/h2,4,7,9-27,29-40H,3,5-6H2,1H3",N/A,3,positive,MONA,684.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C25H43NO18,CEMXHAPUFJOOSV-UHFFFAOYSA-N,CEMXHAPUFJOOSV,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Polyols,Amino cyclitols,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004721671,acarbose,acarbose,Medical,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N,CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O
29,CCMSLIB00004721671,35554,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.842869,470200000,0,11.0614,14,0.00756836,684.203,1,temp/spectra_filtered.mgf35554,1,ACARBOSE,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF028090,[M+K]+,684.211,0,1,N/A,N/A,CC1OC(OC2C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O,"InChI=1S/C25H43NO18/c1-7-13(26-9-2-8(3-27)14(33)18(37)15(9)34)17(36)20(39)24(41-7)44-23-12(6-30)42-25(21(40)19(23)38)43-22(11(32)5-29)16(35)10(31)4-28/h2,4,7,9-27,29-40H,3,5-6H2,1H3",N/A,3,positive,MONA,684.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C25H43NO18,CEMXHAPUFJOOSV-UHFFFAOYSA-N,CEMXHAPUFJOOSV,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Polyols,Amino cyclitols,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004721671,acarbose,acarbose,Medical,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N,CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O
30,CCMSLIB00004721671,34139,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.828504,623350000,0,11.4183,14,0.0078125,684.203,1,temp/spectra_filtered.mgf34139,1,ACARBOSE,N/A,ESI-QFT,isolated,MoNA,MoNA:VF-NPL-QEHF028090,[M+K]+,684.211,0,1,N/A,N/A,CC1OC(OC2C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O,"InChI=1S/C25H43NO18/c1-7-13(26-9-2-8(3-27)14(33)18(37)15(9)34)17(36)20(39)24(41-7)44-23-12(6-30)42-25(21(40)19(23)38)43-22(11(32)5-29)16(35)10(31)4-28/h2,4,7,9-27,29-40H,3,5-6H2,1H3",N/A,3,positive,MONA,684.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C25H43NO18,CEMXHAPUFJOOSV-UHFFFAOYSA-N,CEMXHAPUFJOOSV,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Polyols,Amino cyclitols,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00004721671,acarbose,acarbose,Medical,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N,CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O
31,CCMSLIB00005434451,7369,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.962784,57440000,0,0.244298,8,0.000183105,749.516,1,temp/spectra_filtered.mgf7369,1,Azithromycin - Dark Web Drugs,ESI,Orbitrap,Other,Dorrestein,A. Lu,M+H,749.516,0,1,83905-01-05,N/A,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,"InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",N/A,3,Positive,GNPS-LIBRARY,749.516,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C38H72N2O12,MQTOSJVFKKJCRP-UHFFFAOYSA-N,MQTOSJVFKKJCRP,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Macrolides,Erythromycins,Polyketides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005434451,azithromycin,azithromycin,Medical,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O
32,CCMSLIB00005435595,19959,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.82489,72690000,0,1.05169,11,0.000488281,464.284,1,temp/spectra_filtered.mgf19959,1,tauroursodeoxycholic acid,ESI,Orbitrap,commercial,Dorrestein,A. Jarmusch,M-2H2O+H,464.284,499.297,1,35807-85-3,N/A,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,"1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1",N/A,1,Positive,BILELIB19,464.284,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C26H45NO6S,BHTRKEVKTKCXOH-LBSADWJPSA-N,BHTRKEVKTKCXOH,Lipids and lipid-like molecules,Steroids and steroid derivatives,"Bile acids, alcohols and derivatives",Steroids,Cholane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435595,ursodiol,ursodiol,Endogenous|Medical,no_match,NA,NA,cholesterol inhibitor,BHTRKEVKTKCXOH-LBSADWJPSA-N,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C
33,CCMSLIB00005435779,1283,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.974572,572160000,0,2.08242,9,0.000610352,293.098,1,temp/spectra_filtered.mgf1283,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
34,CCMSLIB00005435779,1538,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.973828,548500000,0,2.39478,9,0.000701904,293.098,1,temp/spectra_filtered.mgf1538,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
35,CCMSLIB00005435779,2536,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.979669,612640000,0,3.12363,10,0.000915527,293.098,1,temp/spectra_filtered.mgf2536,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein,lfnothias,M+H,293.097,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,293.097,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435779,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
36,CCMSLIB00005435780,2456,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.941482,50520000,0,2.51828,11,0.000793457,315.08,1,temp/spectra_filtered.mgf2456,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
37,CCMSLIB00005435780,1188,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.958115,46120000,0,1.84028,12,0.000579834,315.08,1,temp/spectra_filtered.mgf1188,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
38,CCMSLIB00005435780,1444,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.944173,60150000,0,1.84028,10,0.000579834,315.08,1,temp/spectra_filtered.mgf1444,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
39,CCMSLIB00005435780,1783,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.957759,41410000,0,2.22771,10,0.000701904,315.08,1,temp/spectra_filtered.mgf1783,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
40,CCMSLIB00005435780,977,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.948997,40880000,0,1.54971,10,0.000488281,315.079,1,temp/spectra_filtered.mgf977,1,Ethylenediaminetetraacetic acid EDTA,LC-ESI,qTof,Crude,Dorrestein, ,M+Na,315.079,0,1, , ,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)", ,3,Positive,GNPS-LIBRARY,315.079,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H16N2O8,KCXVZYZYPLLWCC-UHFFFAOYSA-N,KCXVZYZYPLLWCC,Organic acids and derivatives,Carboxylic acids and derivatives,Tetracarboxylic acids and derivatives,Small peptides,Aminoacids,Amino acids and Peptides,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435780,edta ,edta ,Background/QAQC,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
41,CCMSLIB00005435812,5287,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.870389,1.9e+08,0,24.0903,2,0.00469971,195.092,1,temp/spectra_filtered.mgf5287,1,Caffeine,LC-ESI,qTof,Isolated,Le Pogam,Turpin,M+H,195.087,194.08,1,95789-13-2, ,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,"1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3", ,3,Positive,GNPS-LIBRARY,195.087,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,Food:Other[Sample Type Detected],C8H10N4O2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,RYYVLZVUVIJVGH,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Pseudoalkaloids,Purine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005435812,caffeine,caffeine,Food|Medical,central nervous system stimulant|methylxanthine,neurology/psychiatry|pulmonary,fatigue|drowsiness|apn√©,adenosine receptor antagonist|phosphodiesterase inhibitor,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Cn1c(=O)c2c(ncn2C)n(C)c1=O
42,CCMSLIB00005464314,1202,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.991935,158380000,0,0.796792,7,0.000213623,268.104,1,temp/spectra_filtered.mgf1202,1,ADENOSINE,ESI,Orbitrap,Commercial,Dorrestein,Kelly Weldon,M+H,268.104,267.097,1,58-61-7,N/A,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,"""InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1""",N/A,1,Positive,GNPS-MSMLS,268.104,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C10H13N5O4,OIRDTQYFTABQOQ-KQYNXXCUSA-N,OIRDTQYFTABQOQ,N/A,N/A,N/A,Nucleosides,Purine nucleos(t)ides,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005464314,adenosine,adenosine,Endogenous|Food|Medical,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW),adenosine receptor agonist,OIRDTQYFTABQOQ-KQYNXXCUSA-N,N=c1[nH]cnc2c1ncn2C1OC(CO)C(O)C1O
43,CCMSLIB00005464314,1658,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.984103,310700000,0,0.341482,7,9.15527e-05,268.104,1,temp/spectra_filtered.mgf1658,1,ADENOSINE,ESI,Orbitrap,Commercial,Dorrestein,Kelly Weldon,M+H,268.104,267.097,1,58-61-7,N/A,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,"""InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1""",N/A,1,Positive,GNPS-MSMLS,268.104,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C10H13N5O4,OIRDTQYFTABQOQ-KQYNXXCUSA-N,OIRDTQYFTABQOQ,N/A,N/A,N/A,Nucleosides,Purine nucleos(t)ides,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005464314,adenosine,adenosine,Endogenous|Food|Medical,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW),adenosine receptor agonist,OIRDTQYFTABQOQ-KQYNXXCUSA-N,N=c1[nH]cnc2c1ncn2C1OC(CO)C(O)C1O
44,CCMSLIB00005464401,344,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.832709,13830000,0,36.7603,5,0.00790405,215.008,1,temp/spectra_filtered.mgf344,1,CITRATE,ESI,Orbitrap,Commercial,Dorrestein,Kelly Weldon,M+Na,215.016,192.027,1,77-92-9,N/A,OC(=O)CC(O)(CC(O)=O)C(O)=O,"""InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)""",N/A,1,Positive,GNPS-MSMLS,215.016,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C6H8O7,KRKNYBCHXYNGOX-UHFFFAOYSA-N,KRKNYBCHXYNGOX,Organic acids and derivatives,Carboxylic acids and derivatives,Tricarboxylic acids and derivatives,Fatty Acids and Conjugates,Hydroxy fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005464401,citric acid,citric acid,Food|Medical,no_match,NA,NA,coagulation factor inhibitor,KRKNYBCHXYNGOX-UHFFFAOYSA-N,O=C(O)CC(O)(CC(=O)O)C(=O)O
45,CCMSLIB00005722953,16080,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.935684,734410000,0,3.69488,7,0.00131226,355.154,1,temp/spectra_filtered.mgf16080,1,"NCGC00180304-03!(E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one [IIN-based: Match]",LC-ESI,Orbitrap,Commercial,Pieter Dorrestein,lfnothias/robinschmid,[M+H]+,355.155,354.147,1,N/A,N/A,COC1=C(C(=O)\\C=C\\C2=CC=C(O)C=C2)C(O)=C(CC=C(C)C)C(O)=C1,"InChI=1S/C21H22O5/c1-13(2)4-10-16-18(24)12-19(26-3)20(21(16)25)17(23)11-7-14-5-8-15(22)9-6-14/h4-9,11-12,22,24-25H,10H2,1-3H3/b11-7+",N/A,3,Positive,GNPS-NIH-NATURALPRODUCTSLIBRARY_ROUND2_POSITIVE,355.155,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C21H22O5,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,ORXQGKIUCDPEAJ,Phenylpropanoids and polyketides,"Linear 1,3-diarylpropanoids",Chalcones and dihydrochalcones,Flavonoids,Chalcones,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005722953,xanthohumol,xanthohumol,Food|Medical,no_match,no_match,no_match,no_match,ORXQGKIUCDPEAJ-YRNVUSSQSA-N,COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)C=Cc1ccc(O)cc1
46,CCMSLIB00005733059,10582,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.820127,70900000,0,0.735106,10,0.000305176,415.145,1,temp/spectra_filtered.mgf10582,1,"Massbank:EQ302004 Flecainide|N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide",ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,415.145,0,1,54143-55-4,N/A,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,"1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)",N/A,3,Positive,MASSBANK,415.145,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C17H20F6N2O3,DJBNUMBKLMJRSA-UHFFFAOYSA-N,DJBNUMBKLMJRSA,N/A,N/A,N/A,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005733059,flecainide,flecainide,Medical,antiarrhythmic,cardiology,ventricular tachycardia (VT)|atrial fibrillation (AF)|ventricular arrhythmias,sodium channel blocker,DJBNUMBKLMJRSA-UHFFFAOYSA-N,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F
47,CCMSLIB00005735276,12950,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.964594,185330000,0,0.789832,16,0.000396729,502.295,1,temp/spectra_filtered.mgf12950,1,Massbank:EQ301903 Fexofenadine|2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]butyl]phenyl]-2-methylpropanoic acid,ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,502.295,0,1,83799-24-0,N/A,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,"1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)",N/A,3,Positive,MASSBANK,502.295,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C32H39NO4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,RWTNPBWLLIMQHL,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005735276,fexofenadine,fexofenadine,Medical,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,RWTNPBWLLIMQHL-UHFFFAOYSA-N,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
48,CCMSLIB00005738623,25534,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.83474,304200000,0,0.655747,8,0.000183105,279.232,1,temp/spectra_filtered.mgf25534,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
49,CCMSLIB00005738623,25919,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.712717,252800000,0,0.327873,6,9.15527e-05,279.232,1,temp/spectra_filtered.mgf25919,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
50,CCMSLIB00005738623,23411,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.891822,694130000,0,0.327873,10,9.15527e-05,279.232,1,temp/spectra_filtered.mgf23411,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
51,CCMSLIB00005738623,28279,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.884938,4.56e+08,0,0.327873,9,9.15527e-05,279.232,1,temp/spectra_filtered.mgf28279,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
52,CCMSLIB00005738623,22880,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.809916,423700000,0,0.327873,8,9.15527e-05,279.232,1,temp/spectra_filtered.mgf22880,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
53,CCMSLIB00005738623,23846,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.868889,394040000,0,0.327873,9,9.15527e-05,279.232,1,temp/spectra_filtered.mgf23846,1,"Massbank:RP030402 ?-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",ESI,qTof,Isolated,Massbank,Massbank,M+H,279.232,0,1,463-40-1,N/A,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,"1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",N/A,3,Positive,MASSBANK,279.232,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H30O2,DTOSIQBPPRVQHS-PDBXOOCHSA-N,DTOSIQBPPRVQHS,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005738623,linolenic acid,linolenic acid,Food|Medical,no_match,NA,NA,omega 3 fatty acid stimulant,DTOSIQBPPRVQHS-PDBXOOCHSA-N,CCC=CCC=CCC=CCCCCCCCC(=O)O
54,CCMSLIB00005755186,7667,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.930128,42840000,0,2.19384,6,0.000610352,278.212,1,temp/spectra_filtered.mgf7667,1,Massbank:TUE00812 Venlafaxine,ESI,qTof,Isolated,Massbank,Massbank,M+H,278.211,0,1,N/A,N/A,CN(C)CC(c1ccc(cc1)OC)C2(CCCCC2)O,"1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",N/A,3,Positive,MASSBANK,278.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C17H27NO2,PNVNVHUZROJLTJ-UHFFFAOYSA-N,PNVNVHUZROJLTJ,Benzenoids,Phenol ethers,Anisoles,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005755186,venlafaxine,venlafaxine,Medical,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,PNVNVHUZROJLTJ-UHFFFAOYSA-N,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1
55,CCMSLIB00005765783,5299,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.906789,281870000,0,1.43871,6,0.000305176,212.118,1,temp/spectra_filtered.mgf5299,1,"Massbank:LU084503 1,3-Diphenylguanidine|1,2-diphenylguanidine",ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,212.118,0,1,102-06-7,N/A,N=C(NC1=CC=CC=C1)NC1=CC=CC=C1,"1S/C13H13N3/c14-13(15-11-7-3-1-4-8-11)16-12-9-5-2-6-10-12/h1-10H,(H3,14,15,16)",N/A,3,Positive,MASSBANK,212.118,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C13H13N3,OWRCNXZUPFZXOS-UHFFFAOYSA-N,OWRCNXZUPFZXOS,N/A,N/A,N/A,,,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005765783,diphenylguanidine,diphenylguanidine,Medical|Industrial,no_match,NA,NA,NA,OWRCNXZUPFZXOS-UHFFFAOYSA-N,N=C(Nc1ccccc1)Nc1ccccc1
56,CCMSLIB00005766124,5174,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.985914,302260000,0,1.01679,5,0.000198364,195.088,1,temp/spectra_filtered.mgf5174,1,"Massbank:LU119903 Caffeine|1,3,7-trimethylpurine-2,6-dione",ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,195.088,0,1,58-08-2,N/A,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,"1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",N/A,3,Positive,MASSBANK,195.088,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C8H10N4O2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,RYYVLZVUVIJVGH,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Pseudoalkaloids,Purine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005766124,caffeine,caffeine,Food|Medical,central nervous system stimulant|methylxanthine,neurology/psychiatry|pulmonary,fatigue|drowsiness|apn√©,adenosine receptor antagonist|phosphodiesterase inhibitor,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Cn1c(=O)c2c(ncn2C)n(C)c1=O
57,CCMSLIB00005766542,16310,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.933909,524450000,0,8.20097,7,0.00228882,279.093,1,temp/spectra_filtered.mgf16310,1,"Massbank:LU130903 Sulfamethazine|4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide",ESI,Hybrid FT,Isolated,Massbank,Massbank,M+H,279.091,0,1,57-68-1,N/A,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,"1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)",N/A,3,Positive,MASSBANK,279.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C12H14N4O2S,ASWVTGNCAZCNNR-UHFFFAOYSA-N,ASWVTGNCAZCNNR,Benzenoids,Benzene and substituted derivatives,Benzenesulfonamides,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00005766542,sulfamethazine,sulfamethazine,Medical|Background/QAQC,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N,Cc1cc(C)[nH]c(=NS(=O)(=O)c2ccc(N)cc2)n1
58,CCMSLIB00006377656,9461,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.933361,75430000,0,0,14,0,303.05,1,temp/spectra_filtered.mgf9461,1,Quercetin,ESI,Orbitrap,Commercial standard,BMDMS-NP,BMDMS-NP,[M+H]+,303.05,302.043,1,N/A,N/A,O=C1C(O)=C(OC=2C=C(O)C=C(O)C12)C=3C=CC(O)=C(O)C3,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",N/A,1,Positive,BMDMS-NP,303.05,UPDATE-SINGLE-ANNOTATED-GOLD,Gold,,C15H10O7,REFJWTPEDVJJIY-UHFFFAOYSA-N,REFJWTPEDVJJIY,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavonoids,Flavonols,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006377656,quercetin,quercetin,Food|Medical,dietary supplement,NA,NA,polar auxin transport inhibitor,REFJWTPEDVJJIY-UHFFFAOYSA-N,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
59,CCMSLIB00006565425,12688,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.836545,664300000,0,1.34433,15,0.000488281,363.216,1,temp/spectra_filtered.mgf12688,1,Cortisol,LC-ESI,qTof,Commercial,Aldo Moreno Ulloa,Aldo Moreno Ulloa,M+H,363.216,362.209,1,50-23-7,5754,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,"1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1", ,3,Positive,GNPS-LIBRARY,363.216,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C21H30O5,JYGXADMDTFJGBT-VWUMJDOOSA-N,JYGXADMDTFJGBT,Lipids and lipid-like molecules,Steroids and steroid derivatives,Hydroxysteroids,Steroids,Pregnane steroids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006565425,hydrocortisone,hydrocortisone,Endogenous|Medical,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,JYGXADMDTFJGBT-VWUMJDOOSA-N,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO
60,CCMSLIB00006679126,4698,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.835275,2.018e+09,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf4698,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,Benzenoids,Phenols,Methoxyphenols,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
61,CCMSLIB00006679126,5909,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.830453,1.88e+09,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf5909,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,Benzenoids,Phenols,Methoxyphenols,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
62,CCMSLIB00006679126,5214,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.821524,1164100000,0,1.20154,3,0.000198364,165.091,1,temp/spectra_filtered.mgf5214,1,ISOEUGENOL,ESI,Orbitrap,isolated,MoNA,MoNA:MoNA038797,M+H,165.091,0,1,N/A,N/A,C/C=C/C1=CC=C(C(=C1)OC)O,"""InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3+""",N/A,3,positive,MONA,165.091,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C10H12O2,BJIOGJUNALELMI-ONEGZZNKSA-N,BJIOGJUNALELMI,Benzenoids,Phenols,Methoxyphenols,Phenylpropanoids (C6-C3),Cinnamic acids and derivatives,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00006679126,isoeugenol,isoeugenol,Medical,no_match,no_match,no_match,no_match,BJIOGJUN/ALELMI-ONEGZZNKSA-N,CC=Cc1ccc(O)c(OC)c1
63,CCMSLIB00010112940,30136,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.856538,133400000,0,7.96057,10,0.00180054,226.18,1,temp/spectra_filtered.mgf30136,1,VITAMIN K1 CollisionEnergy:102040,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+2H],226.182,0,1,N/A,N/A,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,"""InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+""",N/A,3,Positive,BERKELEY-LAB,226.182,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C31H46O2,MBWXNTAXLNYFJB-UHFFFAOYSA-N,MBWXNTAXLNYFJB,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Meroterpenoids,Prenyl quinone meroterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010112940,phytomenadione,phytomenadione,Food|Medical,warfarin reversal agent|vitamin K replacement,hematology,vitamin K deficiency|anticoagulation reversal,vitamin K,MBWXNTAXLNYFJB-NKFFZRIASA-N,CC(C=Cc1c(C)c(O)c2ccccc2c1O)=CCCC(C)CCCC(C)CCCC(C)C
64,CCMSLIB00010114338,29436,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.73309,362500000,0,1.49566,8,0.000396729,265.253,1,temp/spectra_filtered.mgf29436,1,oleic acid CollisionEnergy:102040,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+H-H2O,265.253,0,1,N/A,N/A,CCCCCCCCC=CCCCCCCCC(=O)O,"""InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-""",N/A,3,Positive,BERKELEY-LAB,265.253,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H34O2,ZQPPMHVWECSIRJ-UHFFFAOYSA-N,ZQPPMHVWECSIRJ,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Fatty Acids and Conjugates,Unsaturated fatty acids,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010114338,oleic acid,oleic acid,Food|Medical,no_match,no_match,no_match,no_match,ZQPPMHVWECSIRJ-KTKRTIGZSA-N,CCCCCCCCC=CCCCCCCCC(=O)O
65,CCMSLIB00010114511,29788,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.882018,46210000,0,5.17164,16,0.0032959,637.305,1,temp/spectra_filtered.mgf29788,1,AC1L1X1Z CollisionEnergy:102040,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+Na,637.302,0,1,N/A,N/A,NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O,"""InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22?,23+/m1/s1""",N/A,3,Positive,BERKELEY-LAB,637.302,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C23H46N6O13,PGBHMTALBVVCIT-UHFFFAOYSA-N,PGBHMTALBVVCIT,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Polyols,Amino cyclitols,Carbohydrates,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010114511,framycetin,framycetin,Medical,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N,NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O
66,CCMSLIB00010122114,18893,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.875449,244600000,0,2.00453,9,0.00050354,251.201,1,temp/spectra_filtered.mgf18893,1,Sclareolide CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+H,251.201,0,1,N/A,N/A,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12,"""InChI=1S/C16H26O2/c1-14(2)7-5-8-15(3)11(14)6-9-16(4)12(15)10-13(17)18-16/h11-12H,5-10H2,1-4H3/t11-,12+,15-,16+/m0/s1""",N/A,3,Positive,BERKELEY-LAB,251.201,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H26O2,IMKJGXCIJJXALX-UHFFFAOYSA-N,IMKJGXCIJJXALX,N/A,N/A,N/A,Diterpenoids,Norlabdane diterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010122114,sclareolide,sclareolide,Medical,no_match,NA,NA,other antifungal,IMKJGXCIJJXALX-SHUKQUCYSA-N,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12
67,CCMSLIB00010122115,18897,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.750057,248700000,0,0.458045,8,0.000106812,233.19,1,temp/spectra_filtered.mgf18897,1,Sclareolide CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+H-H2O,233.19,0,1,N/A,N/A,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12,"""InChI=1S/C16H26O2/c1-14(2)7-5-8-15(3)11(14)6-9-16(4)12(15)10-13(17)18-16/h11-12H,5-10H2,1-4H3/t11-,12+,15-,16+/m0/s1""",N/A,3,Positive,BERKELEY-LAB,233.19,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H26O2,IMKJGXCIJJXALX-UHFFFAOYSA-N,IMKJGXCIJJXALX,N/A,N/A,N/A,Diterpenoids,Norlabdane diterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010122115,sclareolide,sclareolide,Medical,no_match,NA,NA,other antifungal,IMKJGXCIJJXALX-SHUKQUCYSA-N,CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12
68,CCMSLIB00010124262,14997,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.732302,33960000,0,8.43281,8,0.00190735,226.18,1,temp/spectra_filtered.mgf14997,1,VITAMIN K1 CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+2H],226.182,0,1,N/A,N/A,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,"""InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+""",N/A,3,Positive,BERKELEY-LAB,226.182,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C31H46O2,MBWXNTAXLNYFJB-UHFFFAOYSA-N,MBWXNTAXLNYFJB,N/A,N/A,N/A,Meroterpenoids,Prenyl quinone meroterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010124262,phytomenadione,phytomenadione,Food|Medical,warfarin reversal agent|vitamin K replacement,hematology,vitamin K deficiency|anticoagulation reversal,vitamin K,MBWXNTAXLNYFJB-NKFFZRIASA-N,CC(C=Cc1c(C)c(O)c2ccccc2c1O)=CCCC(C)CCCC(C)CCCC(C)C
69,CCMSLIB00010125273,38220,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.778795,41340000,0,7.61029,2,0.00421143,553.39,1,temp/spectra_filtered.mgf38220,1,D-.alpha.-Tocopherol Succinate CollisionEnergy:205060,LC-ESI,Orbitrap,Commercial,Trent Northen,JGI,M+Na,553.386,0,1,N/A,N/A,Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C)O2,"""InChI=1S/C33H54O5/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-20-33(8)21-19-28-27(7)31(25(5)26(6)32(28)38-33)37-30(36)18-17-29(34)35/h22-24H,9-21H2,1-8H3,(H,34,35)/t23-,24-,33-/m1/s1""",N/A,3,Positive,BERKELEY-LAB,553.386,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C33H54O5,IELOKBJPULMYRW-UHFFFAOYSA-N,IELOKBJPULMYRW,N/A,N/A,N/A,Meroterpenoids,Prenyl quinone meroterpenoids,Terpenoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010125273,tocopherol succinate,tocopherol succinate,Food|Medical,vitamins,metabolism,vitamin E deficiency,antioxidant,IELOKBJPULMYRW-NJQVLOCASA-N,Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C)O2
70,CCMSLIB00010129864,18589,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.948283,55740000,0,0.444085,7,0.000183105,412.321,1,temp/spectra_filtered.mgf18589,1,benzethonium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,412.321,412.321,1,N/A,N/A,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1,"""InChI=1S/C27H42NO2/c1-26(2,3)22-27(4,5)24-13-15-25(16-14-24)30-20-19-29-18-17-28(6,7)21-23-11-9-8-10-12-23/h8-16H,17-22H2,1-7H3/q+1""",SIYLLGKDQZGJHK-UHFFFAOYSA-N,3,Positive,MCE-DRUG,412.321,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,SIYLLGKDQZGJHK-UHFFFAOYSA-N,SIYLLGKDQZGJHK,Benzenoids,Benzene and substituted derivatives,Phenylpropanes,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010129864,benzethonium ,benzethonium ,Medical|Personal Care|Industrial,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1
71,CCMSLIB00010131160,13028,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.869537,14860000,0,1.4215,7,0.000732422,515.245,1,temp/spectra_filtered.mgf13028,1,Telmisartan,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,515.244,514.237,1,N/A,N/A,CCCc1nc2c(cc(-c3nc4ccccc4n3C)cc2C)n1Cc1ccc(-c2ccccc2C(=O)O)cc1,"""InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)""",RMMXLENWKUUMAY-UHFFFAOYSA-N,3,Positive,MCE-DRUG,515.244,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C33H30N4O2,RMMXLENWKUUMAY-UHFFFAOYSA-N,RMMXLENWKUUMAY,N/A,N/A,N/A,Anthranilic acid alkaloids,Phenazine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010131160,telmisartan ,telmisartan ,Medical,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,RMMXLENWKUUMAY-UHFFFAOYSA-N,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
72,CCMSLIB00010132340,2581,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.743885,196620000,0,37.378,3,0.00994873,266.175,1,temp/spectra_filtered.mgf2581,1,antazoline,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,266.165,265.158,1,N/A,N/A,c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1,"""InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19)""",REYFJDPCWQRWAA-UHFFFAOYSA-N,3,Positive,MCE-DRUG,266.165,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C17H19N3,REYFJDPCWQRWAA-UHFFFAOYSA-N,REYFJDPCWQRWAA,Benzenoids,Benzene and substituted derivatives,Phenylmethylamines,,,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010132340,antazoline ,antazoline ,Medical,histamine-1 (H1) inhibitor,allergy,conjunctivitis|nasal congestion,histamine receptor antagonist,REYFJDPCWQRWAA-UHFFFAOYSA-N,c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1
73,CCMSLIB00010135390,2495,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.865093,2.5e+07,0,1.03631,6,0.000213623,206.139,1,temp/spectra_filtered.mgf2495,1,DL-Panthenol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,206.139,205.131,1,N/A,N/A,CC(C)(CO)C(O)C(=O)NCCCO,"""InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)""",SNPLKNRPJHDVJA-UHFFFAOYSA-N,3,Positive,MCE-DRUG,206.139,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C9H19NO4,SNPLKNRPJHDVJA-UHFFFAOYSA-N,SNPLKNRPJHDVJA,Lipids and lipid-like molecules,Fatty Acyls,Fatty amides,Fatty amides,N-acyl amines,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010135390,dl-panthenol ,dl-panthenol ,Medical|Personal Care,vitamins,gastroenterology|metabolism|dermatology,paralytic ileus|cosmetic,vitamin B5,SNPLKNRPJHDVJA-UHFFFAOYSA-N,CC(C)(CO)C(=O)C(O)NCCCO
74,CCMSLIB00010139352,20792,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.922614,213370000,0,0.367495,2,0.000152588,415.211,1,temp/spectra_filtered.mgf20792,1,Trospium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,415.211,392.222,1,N/A,N/A,O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,"""InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?""",OYYDSUSKLWTMMQ-AIZNXBIQSA-N,3,Positive,MCE-DRUG,415.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,OYYDSUSKLWTMMQ,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010139352,trospium ,trospium ,Medical,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1
75,CCMSLIB00010139352,19694,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.930054,545610000,0,0.0734989,2,3.05176e-05,415.211,1,temp/spectra_filtered.mgf19694,1,Trospium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,415.211,392.222,1,N/A,N/A,O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,"""InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?""",OYYDSUSKLWTMMQ-AIZNXBIQSA-N,3,Positive,MCE-DRUG,415.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,OYYDSUSKLWTMMQ,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010139352,trospium ,trospium ,Medical,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1
76,CCMSLIB00010139352,19991,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.887136,265590000,0,0.367495,2,0.000152588,415.211,1,temp/spectra_filtered.mgf19991,1,Trospium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,415.211,392.222,1,N/A,N/A,O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,"""InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?""",OYYDSUSKLWTMMQ-AIZNXBIQSA-N,3,Positive,MCE-DRUG,415.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,OYYDSUSKLWTMMQ,N/A,N/A,N/A,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010139352,trospium ,trospium ,Medical,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1
77,CCMSLIB00010139352,18879,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.92506,1058500000,0,0.367495,3,0.000152588,415.211,1,temp/spectra_filtered.mgf18879,1,Trospium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,415.211,392.222,1,N/A,N/A,O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,"""InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?""",OYYDSUSKLWTMMQ-AIZNXBIQSA-N,3,Positive,MCE-DRUG,415.211,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,OYYDSUSKLWTMMQ,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010139352,trospium ,trospium ,Medical,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1
78,CCMSLIB00010139511,5974,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.978381,216900000,0,0.113791,13,3.05176e-05,268.191,1,temp/spectra_filtered.mgf5974,1,metoprolol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,268.191,267.183,1,N/A,N/A,COCCc1ccc(OCC(O)CNC(C)C)cc1,"""InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3""",IUBSYMUCCVWXPE-UHFFFAOYSA-N,3,Positive,MCE-DRUG,268.191,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C15H25NO3,IUBSYMUCCVWXPE-UHFFFAOYSA-N,IUBSYMUCCVWXPE,Benzenoids,Phenols,Tyrosols and derivatives,Pseudoalkaloids,Phenylalanine-derived alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010139511,metoprolol ,metoprolol ,Medical,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,IUBSYMUCCVWXPE-UHFFFAOYSA-N,COCCc1ccc(OCC(O)CNC(C)C)cc1
79,CCMSLIB00010143301,8372,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.920386,90390000,0,0.304982,9,249.152,250.159,2,temp/spectra_filtered.mgf8372,1,Azacyclonol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,250.159,267.162,1,N/A,N/A,OC(c1ccccc1)(c1ccccc1)C1CCNCC1,"""InChI=1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2""",ZMISODWVFHHWNR-UHFFFAOYSA-N,3,Positive,MCE-DRUG,250.159,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C18H21NO,ZMISODWVFHHWNR-UHFFFAOYSA-N,ZMISODWVFHHWNR,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,Ornithine alkaloids,Tropane alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010143301,azacyclonol ,azacyclonol ,Medical,no_match,NA,NA,histamine receptor antagonist,ZMISODWVFHHWNR-UHFFFAOYSA-N,OC(c1ccccc1)(c1ccccc1)C1CCNCC1
80,CCMSLIB00010144696,2030,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.991115,87990000,0,0.342676,12,9.15527e-05,267.17,1,temp/spectra_filtered.mgf2030,1,(R)-(+)-Atenolol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,267.17,266.163,1,N/A,N/A,CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1,"""InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/t12-/m1/s1""",METKIMKYRPQLGS-GFCCVEGCSA-N,3,Positive,MCE-DRUG,267.17,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C14H22N2O3,METKIMKYRPQLGS-GFCCVEGCSA-N,METKIMKYRPQLGS,Benzenoids,Benzene and substituted derivatives,Phenylacetamides,Peptide alkaloids,Simple amide alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010144696,atenolol ,atenolol ,Medical,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|acute myocardial infarction,adrenergic receptor antagonist,METKIMKYRPQLGS-GFCCVEGCSA-N,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1
81,CCMSLIB00010147596,8371,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.982703,28240000,0,1.42216,9,0.000549316,386.254,1,temp/spectra_filtered.mgf8371,1,buspirone,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,386.255,385.248,1,N/A,N/A,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,"""InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2""",QWCRAEMEVRGPNT-UHFFFAOYSA-N,3,Positive,MCE-DRUG,386.255,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C21H31N5O2,QWCRAEMEVRGPNT-UHFFFAOYSA-N,QWCRAEMEVRGPNT,Organoheterocyclic compounds,Diazinanes,Piperazines,Lysine alkaloids,Quinolizidine alkaloids,Alkaloids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010147596,buspirone ,buspirone ,Medical,anxiolytics,neurology/psychiatry,generalized anxiety disorder (GAD),serotonin receptor agonist,QWCRAEMEVRGPNT-UHFFFAOYSA-N,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
82,CCMSLIB00010149160,26325,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.935345,3618800000,0,0.406584,11,0.000244141,600.468,1,temp/spectra_filtered.mgf26325,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,Organic oxygen compounds,Organooxygen compounds,Ethers,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
83,CCMSLIB00010149160,25286,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.860736,183720000,0,0.406584,7,0.000244141,600.468,1,temp/spectra_filtered.mgf25286,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,N/A,N/A,N/A,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
84,CCMSLIB00010149160,36649,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.9313,235870000,0,0.406584,8,0.000244141,600.468,1,temp/spectra_filtered.mgf36649,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,Organic oxygen compounds,Organooxygen compounds,Ethers,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
85,CCMSLIB00010149160,36067,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.921916,268730000,0,0.813168,10,0.000488281,600.469,1,temp/spectra_filtered.mgf36067,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,Organic oxygen compounds,Organooxygen compounds,Ethers,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
86,CCMSLIB00010149160,37260,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.929865,234780000,0,0.406584,8,0.000244141,600.468,1,temp/spectra_filtered.mgf37260,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,Organic oxygen compounds,Organooxygen compounds,Ethers,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
87,CCMSLIB00010149160,25881,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.839181,230280000,0,0.406584,7,0.000244141,600.468,1,temp/spectra_filtered.mgf25881,1,Polidocanol,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,600.468,582.434,1,N/A,N/A,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,"""InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3""",ONJQDTZCDSESIW-UHFFFAOYSA-N,3,Positive,MCE-DRUG,600.468,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C30H62O10,ONJQDTZCDSESIW-UHFFFAOYSA-N,ONJQDTZCDSESIW,Organic oxygen compounds,Organooxygen compounds,Ethers,Glycerolipids,Triacylglycerols,Fatty acids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010149160,polidocanol ,polidocanol ,Medical|Low_confidence,sclerosing agent,dermatology,varicose veins,endothelial surface destruction,ONJQDTZCDSESIW-UHFFFAOYSA-N,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
88,CCMSLIB00010151226,10672,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.984209,406070000,0,0.187669,7,6.10352e-05,325.227,1,temp/spectra_filtered.mgf10672,1,Denatonium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,325.227,325.227,1,N/A,N/A,CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1,"""InChI=1S/C21H28N2O/c1-5-23(6-2,15-19-13-8-7-9-14-19)16-20(24)22-21-17(3)11-10-12-18(21)4/h7-14H,5-6,15-16H2,1-4H3/p+1""",ZFQMTVNLDNXRNQ-UHFFFAOYSA-O,3,Positive,MCE-DRUG,325.227,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,ZFQMTVNLDNXRNQ-UHFFFAOYSA-O,ZFQMTVNLDNXRNQ,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010151226,denatonium ,denatonium ,Medical,no_match,NA,NA,NA,ZFQMTVNLDNXRNQ-UHFFFAOYSA-O,CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1
89,CCMSLIB00010152336,22628,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.90501,275400000,0,0.254057,3,9.15527e-05,360.362,1,temp/spectra_filtered.mgf22628,1,Cetalkonium,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,360.362,360.362,1,N/A,N/A,CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,"""InChI=1S/C25H46N/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25/h17-19,21-22H,4-16,20,23-24H2,1-3H3/q+1""",QDYLMAYUEZBUFO-UHFFFAOYSA-N,3,Positive,MCE-DRUG,360.362,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,N/A,QDYLMAYUEZBUFO-UHFFFAOYSA-N,QDYLMAYUEZBUFO,Benzenoids,Benzene and substituted derivatives,Phenylmethylamines,N/A,N/A,N/A,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010152336,cetalkonium ,cetalkonium ,Medical,no_match,NA,NA,cationic surfactant,QDYLMAYUEZBUFO-UHFFFAOYSA-N,CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1
90,CCMSLIB00010152594,34161,spectra_filtered.mgf,GNPS_Drug_Library_Spectra_Drugs_and_Metabolites.mgf,0.947811,377880000,0,0.437279,3,0.00012207,279.159,1,temp/spectra_filtered.mgf34161,1,dibutyl phthalate,ESI,Orbitrap,Crude,Tomas Pluskal,Corinna Brungs,M+H,279.159,278.152,1,N/A,N/A,CCCCOC(=O)c1ccccc1C(=O)OCCCC,"""InChI=1S/C16H22O4/c1-3-5-11-19-15(17)13-9-7-8-10-14(13)16(18)20-12-6-4-2/h7-10H,3-6,11-12H2,1-2H3""",DOIRQSBPFJWKBE-UHFFFAOYSA-N,3,Positive,MCE-DRUG,279.159,UPDATE-SINGLE-ANNOTATED-BRONZE,Bronze,,C16H22O4,DOIRQSBPFJWKBE-UHFFFAOYSA-N,DOIRQSBPFJWKBE,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Phenolic acids (C6-C1),Shikimic acids and derivatives|Simple phenolic acids,Shikimates and Phenylpropanoids,mzspec:GNPS:GNPS-LIBRARY:CCMSLIB00010152594,dibutyl phthalate ,dibutyl phthalate ,Medical|Personal Care|Industrial,no_match,NA,NA,NA,DOIRQSBPFJWKBE-UHFFFAOYSA-N,CCCCOC(=O)c1ccccc1C(=O)OCCCC
